The physiological role of the skeletal muscle-specific calpain 3, p94, is presently unknown, but defects in its gene cause limb girdle muscular dystrophy type 2A. This calcium-dependent cysteine protease resembles the large subunit of m-calpain but with three unique additional sequences: an N-terminal region (NS), and two insertions (IS1 and IS2). The latter two insertions have been linked to the chronic instability of the whole enzyme both in vivo and in vitro. We have shown previously that the core of p94 comprising NS, domains I and II, and IS1 is stable as a recombinant protein in the absence of Ca 2؉ and undergoes autolysis in its presence. Here we show that p94I-II cannot hydrolyze an exogenous substrate before autolysis but is increasingly able to do so when autolysis proceeds for several hours. This gain in activity is caused by cleavage of IS1 during autolysis because a deletion mutant lacking the NS region (p94I-II ⌬NS) shows the same activation profile. Similarly, the calpain inhibitors E-64 and leupeptin have almost no inhibitory effect on substrate hydrolysis by p94I-II soon after calcium addition but cause complete inhibition when autolysis progresses for several hours. As autolysis proceeds, there is release of the internal IS1 peptide, but the two portions of the core remain tightly associated. Modeling of p94I-II suggests that IS1 contains an amphipathic ␣-helix flanked by extended loops. The latter are the targets of autolysis and limited digestion by exogenous proteases. The presence and location of the ␣-helix in recombinant IS1 were confirmed by circular dichroism and by the introduction of a L286P helix-disrupting mutation. Within p94I-II, L286P caused premature autoproteolysis of the enzyme. IS1 is an elaboration of a loop in domain II near the active site, and it acts as an internal autoinhibitory propeptide, blocking the active site of p94 from substrates and inhibitors.
The physiological role of the skeletal muscle-specific calpain 3, p94, is presently unknown, but defects in its gene cause limb girdle muscular dystrophy type 2A. This calcium-dependent cysteine protease resembles the large subunit of m-calpain but with three unique additional sequences: an N-terminal region (NS), and two insertions (IS1 and IS2). The latter two insertions have been linked to the chronic instability of the whole enzyme both in vivo and in vitro. We have shown previously that the core of p94 comprising NS, domains I and II, and IS1 is stable as a recombinant protein in the absence of Ca 2؉ and undergoes autolysis in its presence. Here we show that p94I-II cannot hydrolyze an exogenous substrate before autolysis but is increasingly able to do so when autolysis proceeds for several hours. This gain in activity is caused by cleavage of IS1 during autolysis because a deletion mutant lacking the NS region (p94I-II ⌬NS) shows the same activation profile. Similarly, the calpain inhibitors E-64 and leupeptin have almost no inhibitory effect on substrate hydrolysis by p94I-II soon after calcium addition but cause complete inhibition when autolysis progresses for several hours. As autolysis proceeds, there is release of the internal IS1 peptide, but the two portions of the core remain tightly associated. Modeling of p94I-II suggests that IS1 contains an amphipathic ␣-helix flanked by extended loops. The latter are the targets of autolysis and limited digestion by exogenous proteases. The presence and location of the ␣-helix in recombinant IS1 were confirmed by circular dichroism and by the introduction of a L286P helix-disrupting mutation. Within p94I-II, L286P caused premature autoproteolysis of the enzyme. IS1 is an elaboration of a loop in domain II near the active site, and it acts as an internal autoinhibitory propeptide, blocking the active site of p94 from substrates and inhibitors.
Calpains comprise a large family of cytosolic Ca 2ϩ -dependent cysteine proteinases with homologues present in mammals, insects, nematodes, and yeast (1, 2) . Two well-studied members of this family are the mammalian heterodimeric -and mcalpains, which are composed of a large catalytic subunit (80 kDa) and a small regulatory subunit (28 kDa) . The domain structure of the large subunit was redefined by x-ray crystallography (3, 4) . Following the classification of Hosfield et al. (3) , the large subunit has four structural domains (I-IV). The first two (I and II) make up the papain-like catalytic core common to all calpains (1), whereas domains III and IV are the C2-like and penta-EF-hand domains, respectively. The small subunit contains two domains, V and VI, of which the latter is also a penta-EF-hand domain that forms extensive interactions with the homologous penta-EF-hand domain IV in the large subunit. Several more of the ϳ14 human calpain isoforms are composed of two subunits and share the same domain structure as -and m-calpain. Other calpain homologues do not seem to form heterodimers, and some also contain different domains such as SOH (small optic lobe homologous), PBH (PalB homologous), and T (tra-3 specific) as additions or substitutions. Some members of the calpain family appear to be ubiquitously expressed, whereas others are only found in specific tissues. However, these distinctions may not be as clear-cut as once thought (5) .
Before the discovery of many new calpain genes by way of the Human Genome Project and other sequencing projects, molecular cloning experiments had identified a third member of the calpain superfamily, calpain 3 (p94), whose mRNA was predominantly expressed in skeletal muscle (6) . Based on sequence homology to -and m-calpain (54% and 51% identity, respectively), p94 has a domain organization similar to that of their large subunits (6) . In addition, p94 contains three unique sequences: an N-terminal extension (NS) of 47 amino acids located where the anchor peptide would be in m-calpain, and two insertion sequences. The first insertion sequence (IS1) is 48 amino acids long and interrupts domain II after Asp 267 . This insertion is encoded by a single exon (exon 6). The second insertion of 77 residues is encoded by two exons (exons 15 and 16) and located between domains III and IV (IS2). Although p94 has been modeled to contain all four domains of the large subunit (7), it does not seem to form a heterodimer (8) . Consistent with this theory, protein-protein interaction analysis using the yeast two-hybrid system did not show an interaction between p94 and the 28-kDa small subunit (9) . The importance of p94 in muscle physiology was confirmed by the discovery that mutations in the calpain 3 gene (capn3) lead to limb girdle muscular dystrophy type 2A (10) .
Numerous efforts have been made to isolate p94 from muscle or to produce a recombinant form of the enzyme in Escherichia coli (11, 12) , mammalian cells (11) , or insect cells (12, 13) . These attempts failed to produce large amounts of p94 due to its rapid autolytic degradation, which has hindered a thorough biochemical characterization of the enzyme. As a result, the roles of the three p94-specific sequences and their contribution to the unique properties and physiological function of calpain 3 have remained speculative.
IS1 and IS2 are each thought to contribute to the lack of stability of p94. Splicing variants of p94 lacking these novel insertions have been found in different eye tissues such as lens (Lp82) (14) , retina (Rt88) (15) , and cornea (Cn94) (16) ; in skeletal muscle (17) ; and in peripheral blood mononuclear cells (18) . In contrast to p94, Lp82, the lens-specific calpain isoform that lacks NS, IS1, and IS2, has been detected as a full-length 82-kDa protein band in young rodent lenses, and the corresponding enzymatic activity band has been detected on casein zymograms (19) . Furthermore, a recombinant construct of Lp82 was stably produced in insect cells, purified, and characterized (20) . Very recently, an alternatively spliced variant of mouse skeletal muscle p94 that lacks IS1 and IS2 (p94:exon 6 Ϫ 15 Ϫ 16 Ϫ , p94⌬) has been successfully expressed in mammalian cells and shown to be proteolytically active (21) . Introduction of IS1 into Lp82 destabilized the protein and caused a loss of enzymatic activity, whereas substitution of the shorter Nterminal sequence (AX1) present in Lp82 by NS or introduction of IS2 did not affect stability (22) . These results strongly suggest that the stability and abundance of enzymatically active Lp82 in rodent lens are due to the lack of IS1 and may explain why IS1-containing isoforms of calpains such as p94 and Rt88 (15) are unstable (23) .
Rapid autolysis of p94 during purification from rabbit muscle fractions was not prevented by the calpain inhibitors E-64 (trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane) and leupeptin (8) , whereas autolysis of purified recombinant Lp82 was totally inhibited by E-64 or EGTA (20) . Moreover, a recently reported p94 isoform present in human peripheral blood mononuclear cells that lacks IS1 and the lysine-rich IS2 sequence was also inhibited by leupeptin and calpain inhibitors I and II (18) . In contrast to -and m-calpain, p94 and its splice variants have been shown to be insensitive to inhibition by calpastatin (8, 18, 20) . The basis for this insensitivity is not known, but it could be due in part to the absence of the small subunit, which is one of the defined calpastatin binding sites present in m-calpain (24) .
Unlike whole p94, the proteolytic core of p94 containing NS and IS1 can be produced in relatively large amounts in E. coli, and the recombinant protein is fairly stable during purification (25) . Using this truncated form of the enzyme, we have previously shown that the core of p94 is stable in EDTA but undergoes autolysis in the presence of Ca 2ϩ . NS and IS1 are rapidly cleaved during this process at specific N-terminal sites by a strictly intramolecular reaction (Fig. 1) . Here we have studied the effect of NS and IS1 on p94 enzymatic properties. Our results show that IS1 acts as an internal propeptide. Autoproteolysis serves to remove IS1 (and NS), making the active site available for hydrolysis of exogenous substrates and accessible to inhibitors.
EXPERIMENTAL PROCEDURES
Cloning, Mutagenesis, Expression, and Purification of Recombinant Proteins-The protease core of human p94 (p94I-II) and its active site knockout mutant, p94I-II C129S, were prepared as described previously (25) . These constructs contain NS and IS1 and are effectively a C-terminal truncation of p94 after Asp 419 (Fig. 1) . The subsequent deletion of the NS region was achieved by PCR using expand high-fidelity DNA polymerase (Roche Applied Science) with the p94I-II DNA construct as a template. A new 5Ј primer (5Ј-GATATACATATGATCATCAGCCGCAATTTTCCTAT-3Ј) deleted the first 45 amino acids, i.e. 1 residue C-terminal to the second (2a) autolysis site in NS, and inserted an initiating methionine (Fig. 1) (25) are represented for reference. B, map of tryptic and chymotryptic cleavage sites in p94I-II. NS and IS1 sequences are highlighted in gold boxes, and a putative ␣-helix in IS1 is also indicated by the cylinder. The arrows point to the cleavage sites determined by N-terminal sequencing of the main proteolytic fragments (T1-5 and CH1-5).
kanamycin selection. This deletion construct was purified according to the protocol described previously for p94I-II (25) , but with size-exclusion chromatography on Sephacryl S-200 included before the final Q-Sepharose fast protein liquid chromatography.
The 48-amino acid IS1 sequence was amplified by PCR and ligated into the pET28a(ϩ) vector between the NdeI and XhoI sites. The recombinant IS1 was expressed as a 68-residue His-tagged polypeptide in E. coli BL21(DE3) at room temperature under kanamycin selection. It was purified from the supernatant fraction by metal affinity chromatography on a Ni-NTA 1 -agarose column followed by reversed-phase HPLC on a C18 semi-preparative column.
The L286P helix-breaking mutation was introduced into p94I-II, its active site knockout mutant (p94I-II C129S), and IS1 by site-directed mutagenesis using the single-stranded DNA method of Kunkel et al. (26) . The mutants were expressed and purified using the same procedure as the wild-type proteins.
Enzyme Assays-Autoproteolytic activity was measured by incubating either p94I-II or its deletion construct p94I-II ⌬NS in 50 mM HEPES-NaOH (pH 7.6), 10 mM Ca 2ϩ at room temperature in a final volume of 200 -500 l at a protein concentration of 0.5 mg/ml. Aliquots were removed at different times, and the reaction was stopped by the addition of 3ϫ SDS sample buffer, 187.5 mM Tris-HCl (pH 6.8), 6% SDS, 30% glycerol, and 0.03% bromphenol blue. The progress of autolysis was analyzed by 10% SDS-PAGE and Coomassie Blue staining. The control assay was done with 10 mM EDTA in place of Ca 2ϩ . The activity of p94I-II and p94I-II ⌬NS against a 0.5 mM solution of the fluorogenic peptide substrate succinyl-Leu-Tyr (SLY)-aminomethyl coumarin (MCA) was assayed in 50 mM HEPES-NaOH (pH 7.6), 200 mM NaCl, 1 mM dithiothreitol, and 10 mM Ca 2ϩ at room temperature. MCA release was monitored over time (excitation at 360 nm and emission at 460 nm). To examine the effect of autolysis on the rate of SLY-MCA hydrolysis, 5 M p94I-II or p94I-II ⌬NS was incubated in 50 mM HEPES-NaOH (pH 7.6), 200 mM NaCl, 1 mM dithiothreitol, and 10 mM Ca 2ϩ . Aliquots were removed at different autolysis times and assayed for hydrolysis of SLY-MCA (0.5 mM). The initial rate of MCA release was calculated for each autolysis time point, and the degree of autolysis was analyzed by SDS-PAGE. The effect of two calpain inhibitors, leupeptin and E-64, on the hydrolysis of SLY-MCA by p94I-II and p94I-II ⌬NS was tested at different autolysis times. MCA release was monitored for 20 -30 min before the addition of a 40-fold molar excess of inhibitor.
Binding of p94I-II Autolytic Fragments to a Nickel Chelation Matrix-Autolysis fragments produced after 24 h of incubation of p94I-II in 50 mM HEPES-NaOH (pH 7.6), 200 mM NaCl, 1 mM dithiothreitol, and 10 mM Ca 2ϩ at room temperature were loaded on a Ni-NTA column (Qiagen) previously equilibrated in 25 mM Tris-HCl (pH 7.6), 100 mM NaCl, 5 mM imidazole, and 2% glycerol (N-buffer). Unbound material was collected in the flow-through fractions, and two wash steps with N-buffer were performed before bound material was eluted with 250 mM imidazole in N-buffer (pH 8.5). Fractions from the column were analyzed by SDS-PAGE on a 10% gel.
Modeling of p94I-II ⌬NS-Secondary structure predictions were performed with the web-based servers for PredictProtein (27, 28) , nnpredict (29) , and 3D-PSSM (30) . The propensity for globularity and disorder was also predicted using the GlobPlot server. The sequence of p94I-II was modeled onto the structure of the rat I-II protease core (31) using the Sybyl software program (Tripos, Inc.). Homologous regions were restrained to the rat I-II structure. The structure of IS1 was manually built into place and subjected to energy minimization and molecular dynamics.
CD Spectroscopy-CD spectra were recorded on an Olis RSM 1000 CD spectrophotometer using a 1-mm path length quartz cell. Data collection (260 -180 nm) was done at 4°C in 10 mM sodium phosphate buffer (pH 7.6), with and without 10% and 50% trifluoroethanol (TFE). The protein concentration of HPLC-pure IS1 polypeptide and its L286P mutant was 0.25 mg/ml. CD spectra were averages of at least 10 scans corrected for buffer background signal. Deconvolution of the spectra was done using the CDNN software (32) . The results are expressed as mean residue molar ellipticity [⌰] (degrees cm 2 dmol Ϫ1 ). Limited Proteolysis-A time course of limited proteolytic digestion of the inactive mutant of p94I-II by trypsin or chymotrypsin was performed at room temperature in 50 mM HEPES-NaOH (pH 7.6), 1 mM Ca 2ϩ . The inactive mutant was used as substrate to avoid the complication of autolytic processing. The final concentration of p94I-II C129S was 1 mg/ml, whereas the concentrations of trypsin and chymotrypsin were 1 and 100 g/ml, respectively. Aliquots were removed at different time points, and the proteolytic fragments were analyzed by 10% SDS-PAGE and Coomassie Blue staining. Protein fragments were transferred to polyvinylidene difluoride membranes and immunoblotted with an anti-IS1 antibody (RP2-CP3; Triple Point Biologics, Portland, OR) to identify the IS1-linked fragments.
N-terminal Sequencing and Mass Analysis-The protein fragments generated by tryptic and chymotryptic proteolysis were electroblotted onto a polyvinylidene difluoride membrane using 10 mM CAPS-NaOH (pH 11.0), 10% methanol as transfer buffer and visualized using Coomassie Blue R-250 (0.1% dye in 50% methanol). After destaining, the membrane was washed several times with distilled water. Bands corresponding to the main proteolytically resistant products were cut out for N-terminal sequencing (Alberta Peptide Institute, Edmonton, Alberta, Canada). Quadrupole time-of-flight liquid chromatography-mass spectrometry spectra of p94I-II fragments after 24 h of autolysis were acquired at the Protein Function Discovery Facility, Queen's University.
RESULTS
p94I-II Gains Activity during Autolysis-Previously, this laboratory showed that the protease core of p94 (p94I-II) can autolyze in the presence of Ca 2ϩ and that the first cuts made (near the N-terminal ends of NS and IS1) were strictly intramolecular (25) . It was not possible to say whether the subsequent cuts, made near the C-terminal ends of NS and IS1, were intra-or intermolecular. We noted, however, that the combination of early and late cuts had the potential to remove NS and IS1, and speculated that either or both of these sequences might block access to the active site of p94 and prevent it from cleaving exogenous substrates.
To test this hypothesis, we incubated p94I-II with the small synthetic calpain substrate SLY-MCA. At the point when Ca 2ϩ was added, there was no hydrolysis of SLY-MCA by p94I-II ( Fig. 2A) . Cleavage was detected soon after, however, and gradually increased in rate over 25 min. All activity was then abruptly stopped by the addition of 10 mM EDTA. Mg 2ϩ did not substitute for Ca 2ϩ in priming the reaction, nor did it interfere with the priming when Ca 2ϩ was subsequently added. The initial rate of SLY-MCA hydrolysis catalyzed by p94I-II was very weak in comparison with that of the proteolytic core of the -calpain standard (I-II), even when assayed at a 10-or 20-fold higher concentration (Fig. 2B) . However, the enzymatic activity of p94I-II improved considerably when it was allowed to autoproteolyze before the addition of exogenous substrate (Fig. 3A, inset) . The plot of initial reaction rates versus autolysis times showed that the beneficial effect of autolytic preincubation on enzymatic activity was maximal between 10 and 24 h of autolysis (Fig. 3A) .
SDS-PAGE showed a correlation between the gain in SLY-MCA hydrolyzing activity and the extent of p94I-II autoproteolysis. The generation of fragments of ϳ30 and 17 kDa accompanied the early, rapid increase in enzymatic activity in the first hours of autolysis (Fig. 3B) . The 30-kDa fragment is bounded by cleavages at 1a and 1b near the N termini of NS and IS1, respectively (Fig. 1A) , and the 17-kDa fragment is the C-terminal portion of p94I-II from 1b onward (25) . Further increase in enzymatic activity coincided with the generation of two new cleavage products at ϳ26 and 13 kDa, which correspond to protein fragments generated after autolytic cleavage at or near the C termini of NS and IS1 (2a and 2b), respectively.
Cleavages at positions 1a and 2a and at positions 1b and 2b have the potential to release polypeptides corresponding to major portions of NS and IS1, respectively (Fig. 1A) . The generation of these fragments was confirmed by mass spectrometry. Liquid chromatography-mass spectrometry analysis of the 24 h autolysis sample showed prominent peaks of masses 4500.96 and 2829.28 Da consistent with the theoretical masses 1 The abbreviations used are: Ni-NTA, nickel-nitrilotriacetic acid; SLY, succinyl-leucine-tyrosine; MCA, aminomethyl coumarin; CAPS, 3-(cyclohexylamino)propanesulfonic acid; HPLC, high pressure liquid chromatography; TFE, trifluoroethanol.
of the IS1 peptide from 1b to 2b (4502.97 Da) and the NS peptide from 1a to one amino acid before 2a (2830.07 Da) (data not shown). Autolysis at the two internal sites (1b and 2b) that release the IS1 peptide did not, however, result in dissociation of the 26-and 13-kDa fragments of the enzyme. This was demonstrated by chromatography of the 24 h autolysis products on a Ni-NTA resin. The material that bound to the column and was eluted by imidazole was indistinguishable from the 24 h autolysis products in the number and stoichiometry of fragments detected by SDS-PAGE (Fig. 4A) . In particular, the 26-kDa fragment corresponding to the region between NS and IS1 lacks a His tag and could only be retained on the column if this fragment remained tightly bound to the His-tagged Cterminal fragment (13 kDa). Analysis of the three-dimensional structure of the -calpain protease core (31) shows that the equivalent regions of I-II (shown in red and yellow in Fig. 4B ) lie on either side of the loop formed by residues Asn 253 to Arg 267 (shown in green in Fig. 4B ) and display extensive interactions within the overall protein fold. These interactions are composed of a large interdomain surface and the insertion of ␤-strand 14 between ␤-strands 7 and 8 to form a ␤-sheet (Fig.  4B ). According to model building, these interactions are largely conserved in p94I-II (7). p94I-II Active Site Becomes More Accessible to Inhibitors after Extensive Autolysis-Another demonstration of the increasing accessibility of the active site during autolysis was provided by inhibitor studies. A 40-fold molar excess of the calpain active site inhibitors, E-64 and leupeptin, had relatively little inhibitory effect on SLY-MCA hydrolysis by p94I-II during the early stages of Ca 2ϩ addition (Fig. 5, A and B , traces 0.5), whereas hydrolysis of this substrate was completely (E-64) or largely (leupeptin) inhibited when the same concentration of inhibitors was added to a p94I-II sample that had been in the presence of Ca 2ϩ for 24 h (Fig. 5, A and B, traces 24 ). An intermediate degree of inhibition was observed after the enzyme was incubated with Ca 2ϩ for 2, 4, and 10 h (Fig. 5, A and  B, traces 2, 4, and 10) , suggesting that the active site of p94I-II becomes increasingly available to small inhibitors as autolysis progresses. Fig. 5C shows the plots of activation (circles) and inhibition by leupeptin (triangles) and E-64 (squares) as a function of time of autolysis. There is a consistent reciprocal trend between p94 activation and inhibition. SDS-PAGE analysis of autolysis of p94I-II in the presence of a 40-fold molar excess of leupeptin and E-64 shows that both inhibitors were unable to prevent or retard the early autolytic cleavages that generate the 30-and 17-kDa fragments (Fig. 5D) . However, the later autoproteolytic cuts that produce the 26-and 13-kDa fragments were significantly inhibited. Taken together, these results strongly suggest that NS or IS1 or both NS and IS1 hinder the access of substrates and inhibitors to the active site of the p94 proteolytic core and that full enzymatic activity and inhibition are only attainable after removal of these sequences.
Deletion of the N-terminal Insertion Sequence NS Does Not Affect p94I-II Activity-Because p94I-II autolysis releases both NS and IS1, the previous analysis does not distinguish which of these sequences is responsible for keeping the enzyme silent, or whether they cooperate to regulate its activity. To investigate the involvement of the NS sequence, we cloned and expressed a deletion mutant of p94I-II that lacks this N-terminal region (p94I-II ⌬NS).
The expression levels and purification yields of p94I-II ⌬NS were similar to those obtained for wild-type p94I-II (25) . The NS deletion mutant was very stable throughout purification in buffers containing EDTA and was not accompanied by the traces of cleavage product seen in p94I-II preparations (Fig.  6D, lane wt) . In the presence of 10 mM Ca 2ϩ , p94I-II ⌬NS underwent rapid autolysis that was detectable after only 2 min. SDS-PAGE showed accumulation of two major bands of ϳ26 and 17 kDa during the first 4 h of autolysis. The larger of these two fragments corresponded to the 30-kDa cleavage product of p94I-II minus the NS sequence, and the smaller fragment matched the 17-kDa C-terminal fragment. From 4 h onward, there was increasing cleavage of the 17-kDa band to a 13-kDa fragment consistent with the release of IS1, whereas the 26-kDa band remained largely intact up to 24 h. No autolytic products were observed in the presence of 10 mM EDTA (Fig.  6D, lanes C) , which is consistent with autolysis of p94I-II ⌬NS being a Ca 2ϩ -dependent process. The gain in SLY-MCA hydrolyzing activity of the deletion mutant during autolysis was qualitatively and quantitatively similar to that shown by wild-type p94I-II (Fig. 6, A and C) . The hydrolysis of SLY-MCA was barely detectable during the early stages of autolysis (Fig. 6A, trace 0.3) , but it increased after several hours and reached plateau values at 10 -24 h, around the same time as the reaction catalyzed by the wild type.
Inhibition by E-64 (Fig. 6, B and C) showed that the active site of the deletion mutant became more accessible to inhibitors as autolysis progressed. As observed with the wild type, the extent of inhibition in comparison with initial activity increased dramatically over the period of autolysis of p94I-II ⌬NS. These results indicate that the absence of NS does not contribute to the activation of the proteolytic core of p94, and they strongly suggest that the enzyme can only become fully active after IS1 release. sible/flexible regions of p94I-II. Partial proteolysis experiments were done using the inactive C129S mutant of p94I-II to eliminate digestion due to autolysis. The time course of tryptic digestion revealed by SDS-PAGE shows a relatively simple pattern of proteolysis (Fig. 7A) . The 47-kDa starting material was quickly truncated (T-1) and then rapidly broken down to a series (T-2, T-3, and T-4) of large (27-23 kDa) and small (e.g. T-5) (10-kDa) fragments. N-terminal sequencing of these fragments revealed that the first four (T-1 to T-4) all started with the same sequence 50 NFPII, resulting from cleavage after Arg 49 , which is the closest trypsin cleavage site to the 2a autolysis site (Fig. 1) . The N-terminal sequence of T-5 began 316 TIIPV and resulted from cleavage at precisely the 2b autolysis site at the C-terminal end of IS1. A Western blot of the gel in Fig. 7A was probed with antibody made to a peptide comprising the first 30 amino acids in IS1 (Fig. 7C) . The antibody reacted with the starting material and tryptic fragments T-1, T-2, and T-3, but not with T-4 or T-5.
IS1 and NS Are Flanked by Flexible, Exposed Regions That
The simplest interpretation of these results is that NS is quickly removed from p94I-II to produce T-1, which is then cut at the 2b site to generate T-5 and T-2. It is quite likely that T-2 extends up to T-5 and encompasses all of IS1. Subsequently, there are C-terminal cleavages of T-2 at arginines within IS1 to generate T-3 and T-4. The latter cleavage either splits or removes the epitope used to raise the anti-IS1 antibody, accounting for the negative reaction with the antibody.
The progression of chymotryptic digestion revealed by SDS-PAGE is similar to but slightly more complex than the tryptic pattern (Fig. 7B) . The 47-kDa starting material was again rapidly truncated, giving rise to CH-1, and then rapidly broken down to a series of fragments, the major ones of which (CH-2, CH-3, CH-4, and CH-5) range from 32 to 12 kDa. N-terminal sequencing of these fragments revealed that the largest three (CH-1, CH-2, and CH-3) all started with the same sequence ( 44 SAIISR) resulting from cleavage after Tyr 43 , which is the closest chymotryptic site to the 2a autolysis site (Fig. 1) . CH-5 was similar in size to T5, and its N-terminal sequence began 323 ETRMA just 7 residues C-terminal of the 2b autolysis site. The intermediate-sized fragment CH-4 resulted from cleavage precisely at the 1b autolysis site near the N-terminal end of IS1 ( 275 GTSPSG). A Western blot of the chymotryptic digest in Fig.  7B probed with anti-IS1 antibody (Fig. 7D ) detected fragments CH-1, CH-2, and CH-4, but not CH-3 or CH-5.
The most parsimonious interpretation of these results is that NS is once again quickly removed from p94I-II to produce CH-1. CH-1 is then cut in two different ways, either at autolysis site 1b to generate CH-3 and CH-4 or just downstream of the autolysis site 2b to produce CH-2 and CH-5. This alternative cleavage pattern explains why immunoreactive IS1 is present in both an N-terminal (CH-2) and a Cterminal (CH-4) fragment. Subsequently, reciprocal cutting at the other chymotryptic site generates CH-3 from CH-2 and CH-5 from CH-4, releasing IS1 in the process and explaining why CH-3 and CH-5 predominate in the late-stage digests (5-24h).
Modeling of p94I-II ⌬NS-Using the experimental data presented above, the high sequence identity between the proteolytic cores of p94 and -calpain, and the knowledge that the protease core Ca 2ϩ -binding residues are identical in these isoforms, we have modeled p94I-II ⌬NS based on the known crystal structure of Ca 2ϩ -bound rat I-II (31) together with secondary structure predictions for the IS1 region. Three different secondary structure prediction programs predicted an amphipathic ␣-helix within IS1 between residues Met 283 and Ser 297 (Fig. 9A) . The prediction of secondary structures by these three programs agreed well with the observed secondary structures in the homologous regions of the I-II and m-calpain structures. The propensity for globularity and disorder was also predicted using the GlobPlot server (33) . A higher propensity for globularity was found in the regions where helices have been predicted, whereas a higher propensity for disorder was found in the regions where loops have been modeled. p94I-II ⌬NS was modeled onto the structure of the rat I-II using the Sybyl software program (Fig. 8) . Homologous regions were restrained to the rat I-II structure. The putative amphipathic helix in IS1 was docked near the active site cleft with its hydrophobic surface against a hydrophobic region of the protease core (Fig. 8, B and C) . The loop regions preceding and following this helix were manually built into place. We also modeled a short sequence of 14 residues (Thr 316 -Gly 329 ) downstream of IS1 (shown in green in Fig. 8A ) that does not share significant homology to -or m-calpain. A short helix was also predicted for the stretch between Glu 323 and Met 326 within this region. The structure was subjected to energy minimization and molecular dynamics with the homologous regions restrained to the initial coordinates.
In our model, IS1 is protruding out of the main core and occluding the active site cleft without disrupting the rest of the core structure. The autolysis sites are located in flexible loops that are exposed to the attack by other proteases, and the early autolysis site in IS1 (1b) is located in the vicinity of the active site Cys. The rest of the protein is predicted to form a compact core with extensive surface contacts between the two proteolytic domains, which accounts for the stability of p94I-II even after release of the internal IS1 peptide.
Validation of the Model-To avoid trying to detect this single ␣-helix against a high background of helix content from the whole protease core, we have expressed IS1 in E. coli as a recombinant polypeptide. This 68-amino acid domain (IS1 plus N-terminal His-tagged leader sequence) (Fig. 9A ) had 11% ␣-helix content when measured by CD in 10 mM sodium phosphate (pH 7.6) at 4°C (Fig. 9B, solid black line) . This increased to 16% ␣-helix in 10% TFE and to 25% ␣-helix in 50% TFE (dashed and dash-dotted black lines, respectively, in Fig. 9B) . These values are in very good agreement with three different secondary structure programs that predicted an ␣-helix content ranging from 10% to 24% (Fig. 9A) . Next we confirmed the location of the ␣-helix in IS1 by mutating Leu 286 (approximately one-third of the way into the helix) to Pro. This helixbreaking mutation reduced the ␣-helix content of IS1 by roughly a third, which is consistent with disruption of the shorter portion of the helix up to residue 286. Comparing the IS1 CD traces at 0%, 10%, and 50% TFE for the wild type (solid, dashed, and dash-dotted black lines, respectively) and L286P mutant (solid, dashed, and dash-dotted gray lines, respectively) illustrates this (Fig. 9B) .
The most dramatic result came from introducing the same L286P ␣-helix-disrupting mutation in IS1 into whole p94I-II. When this protein was produced in E. coli, it was prematurely activated and cleaved at the early autoproteolysis site near the N-terminal end of IS1 (Fig. 10) . The extent of this cleavage became increasingly apparent during the purification process. SDS-PAGE analysis of fractions from the penultimate step, Sephacryl S-200 chromatography, showed that the 30-and 17-kDa cleavage products were the major proteins present in the sample and that there was very little intact p94I-II left. In contrast, the same L286P mutation had no effect on p94I-II integrity when the active site was inactivated by the C129S mutation. This mutant protein remained intact during purification and co-migrated with the wild-type enzyme. The integrity of the ␣-helix in IS1 is therefore crucial to the orderly activation of the enzyme.
DISCUSSION
In calpain 3, one of the two unique insertion sequences (IS1) is a 48-amino acid segment interposed immediately after ␤-strand 8, ϳ20 residues upstream of the active site His. Our data show that IS1 functions as an internal propeptide that must be autoproteolytically removed from the vicinity of the active site before the enzyme can accept exogenous substrates   FIG. 4 . A, binding of p94I-II autolysis fragments to Ni-NTA. Autoproteolytic fragments (marked as 24 h) generated after 24 h of incubation in 10 mM Ca 2ϩ were loaded on a Ni-NTA column. Unbound sample (flow through, FT), wash fraction (W), and bound material eluted with 250 mM imidazole (E) were collected and analyzed on SDS-PAGE (10%). Lane M represents the molecular mass markers. k, kDa. B, molecular surface representation of rat I-II according to Moldoveanu et al. (31) . The loop formed by residues Asn 253 to Arg 267 , which is the sequence replaced by IS1 in p94I-II, is shown in green. The well-conserved regions on both sides of this loop are colored in red (N-terminal portion) and yellow (C-terminal portion). A close-up of the ␤-sheet formed by ␤-strands 7, 8, and 14 is represented as a ribbon diagram. This figure was generated using Pymol (www.pymol.org).
or inhibitors. When the protease core of p94 is incubated with even small calpain substrates such as SLY-MCA, there is no hydrolysis until the early autolysis sites near the N termini of NS (1a) and IS1 (1b) are cleaved. These initial cuts commence within the time it takes to sample the reaction after the addition of Ca 2ϩ , suggesting that 1a and 1b are physically very close to the active site Cys. Despite the presumed proximity of the N-terminal end of NS to the active site cleft, NS appears not to function as a propeptide because the activation of p94I-II ⌬NS is indistinguishable from that of p94I-II.
The activity of p94I-II ⌬NS or p94I-II against an exogenous substrate increases during autolysis and approaches plateau values around the time when the 2b autolysis site is cleaved near the C-terminal end of IS1, and intact IS1 can be detected in the digests by mass spectrometry. We suggest that the initial N-terminal cleavage may allow IS1 to be displaced from the 10) and leupeptin (lanes 11-14) . Lane C represents a control reaction where Ca 2ϩ has been replaced by 10 mM EDTA, and lane M refers to the molecular mass markers (k, kDa). Main autolytic bands at 30, 26, 17, and 13 kDa are indicated by arrows.
active site cleft, which would then open the latter to substrate and inhibitors. However, while still tethered to the enzyme by the C-terminal connection, it can perhaps more loosely interact with the core and compete with substrate for binding to the active site. Maximal activity is reached only after the C-terminal connection is severed at 2b (likely in an intermolecular reaction by other activated p94I-II protease cores), and the IS1 sequence is free to dissociate from the enzyme. Similarly, inhibitors cannot gain access to the active site cleft until IS1 is displaced, and they will compete with IS1 for binding until the latter is removed. Consistent with this, leupeptin and E64 are completely unable to prevent the first autolytic cleavages at 1a and 1b but efficiently inhibit autolysis at 2a and 2b (Fig. 5D) .
The sequences flanking the internal autolysis sites in NS and IS1 are highly susceptible to cleavage by exogenous proteases. This is particularly true of the C-terminal sites (2a and 2b), which are rapidly cleaved by both trypsin and chymotrypsin. The N-terminal end of IS1 is cut by chymotrypsin but not by trypsin. The failure of trypsin to cut could simply reflect the absence of Arg or Lys in the vicinity of the 1b autolysis site. This proteolysis suggests that the junctions of NS and IS1 with the core are flexible and accessible. In contrast, the internal portion of IS1 is more resistant to attack, either because it is more structured, as for example in the ␣-helical section, or because it is bound to the core and is sterically unavailable to attack.
Full-length p94 is so rapidly autoproteolyzed that it has not been possible to demonstrate its proteolytic activity in muscle homogenates using classical calpain substrates such as casein. However, a unique casein zymogram band corresponding to Lp82, a lens-specific p94 splice variant lacking the two insertion sequences, has been detected in Ca 2ϩ -activated young rat lens homogenates (19) . Aside from missing the two insertion sequences, Lp82 has a different N-terminal sequence in place of NS. Very recently, a new splice variant of p94, which lacks IS1 and the lysine-rich sequence in IS2, has been found in human peripheral blood cells and is active in casein zymograms (18) . Moreover, an alternatively spliced variant of mouse skeletal muscle p94 that lacks IS1 and IS2 (p94⌬) has been successfully expressed in mammalian cells and shown to be proteolytically active (21) .
Introduction of IS1 into Lp82 abolished enzymatic activity, whereas substitution of the shorter N-terminal sequence of Lp82 (encoded by alternative exon 1, AX1) by the longer NS present in p94 did not affect stability or enzymatic activity (22) . Rt88 is another naturally occurring splice variant of p94, which is only different from Lp82 in that it retains the IS1 region. It too has been shown to be active in zymograms, but no protein band corresponding to the full-length Rt88 was found, and only its autolytic fragments could be detected on Western blots (15) .
In general, the calpain 3 derivatives seem to be stable and enzymatically active in vitro when the insertion sequences are absent. However, they are at least initially less active when IS1 is present, and they undergo autolysis. These observations on the whole enzymes are consistent with IS1 serving as a propeptide in p94. Indeed, autolytic cleavage of the full-length enzyme seen by SDS-PAGE may have been misconstrued as "degradation" of the enzyme rather than its activation by removal of the internal IS1 region from the active site cleft.
In support of the latter hypothesis, we have shown here that the enzymatic activity of a recombinant construct comprising the proteolytic core of p94, either with or without the NS sequence, increases as autolysis progresses, suggesting that the loss of IS1 leads to enzyme activation. The central IS1 ␣-helix appears to be a key structural element in the activation mechanism. When a helix-breaking proline is introduced at Leu 286 , the enzyme is prematurely activated, suggesting that the integrity of the helix is important for the orderly activation of p94. We have also shown that the two fragments produced during autolysis, each of which contains catalytic residues, do not dissociate but remain together in the presence of Ca 2ϩ . The homology model presented here shows that there are extensive surface contacts between the two proteolytic domains that account for the tight association of these fragments, even after The side chains atoms of the active site residues are orange (sulfur), red (oxygen), and dark blue (nitrogen), and the red lines indicate the autoproteolytic sites 1b and 2b. B and C, two views of the putative amphipathic ␣-helix in IS1. The helix is drawn in stick form against a semitransparent molecular surface of the protease core. Acidic residues are red, basic residues are blue, nonionic polar residues are turquoise, and hydrophobic residues are white. This figure was generated using Pymol (www.pymol.org).
the internal IS1 peptide is removed.
The inhibitor studies done with calpain 3 derivatives also support our model of autoinhibition. E-64 and leupeptin could not prevent degradation of p94 in muscle extracts or in heterologous expression systems (8), presumably because IS1 restricts access to the active site cleft. In contrast, caseinolytic activity of Lp82 (where IS1 is missing) was completely inhibited by the E-64 or EGTA (20) . Furthermore, leupeptin and calpain inhibitors I and II effectively inhibit the splice variant of p94 present in peripheral blood mononuclear cells that lacks IS1 (18) . Leupeptin, E-64, and calpeptin, among other calpain inhibitors, inhibited the proteolytic activity of mouse skeletal muscle p94 that lacks IS1 and IS2 (p94⌬) (21) . Our results show that complete inhibition of proteolytic activity in p94I-II (and its deletion mutant p94I-II ⌬NS) by E-64 and leupeptin can only be detected after several hours of Ca 2ϩ -dependent autolysis, suggesting that accessibility to the active site is hindered by the presence of IS1 in non-autolyzed p94I-II.
Typically, zymogen conversion to the active enzyme involves limited proteolysis and removal of a propeptide (see Refs. 34 and 35 for review). Prosegments commonly block an otherwise preformed active site, although in some cases, they cause severe distortion of the molecule, preventing the formation of a functional active site. Propeptides are often localized at the N terminus of the zymogens, but they have also been found at the C terminus of some cysteine proteases such as the mammalian and plant asparagine endopeptidases also known as legumains (36, 37) and Arg-gingipain (38) . Some serine peptidases such as aqualysin I (39, 40) and Serratia marcescens serine protease (41) have also a C-terminal propeptide. The existence of an internal "propeptide" has only been reported for the serine carboxypeptidase human protective protein (42) . Activation of human protective protein involves removal FIG. 9 . The ␣-helix content and location in IS1. A, the sequence of recombinant IS1 is shown at the top with the N-terminal leader in italic. H 6 is the His 6 affinity tag. The IS1 sequence proper (Asp 268 to Arg 315 ) is in bold, and the Leu 286 , the site of the proline insertion, is underlined. Secondary structure predictions by the web-based programs nnpredict, 3D-PSSM, and PredictProtein are shown at the below. H signifies a residue in ␣-helix, and E signifies a residue in ␤-strand. B, plot of molar ellipticity as a function of wavelength. Spectra for the wild-type IS1 and its L286P mutant are shown in black and gray, respectively, and were collected in the presence of 0%, 10%, and 50% TFE, as shown by the solid, dashed, and dash-dotted lines, respectively.
FIG. 10.
Purification of p94I-II helix-breaking mutants. The p94 protease core containing the L286P mutation in the wild-type or C129S (inactive) versions was purified as described under "Experimental Procedures." For the former, aliquots of the E. coli supernatant (Supe) and pellet fractions were separated by SDS-PAGE alongside peak fractions from the DEAE-cellulose (DEAE), Ni-NTA, and Sephacryl S-200 (S-200) chromatographies. Lane M represents the molecular mass standards, with their masses in kDa displayed to the left of the gel. The control sample is wild-type p94I-II (wt), and next to it are the ultimate (Q-Seph) and penultimate (S-200) purification stages of the double mutant p94I-II C129S,L286P.
of an "activation segment" inserted between the catalytic residues. The N-and C-terminal portions of the enzyme remain covalently linked by two disulfide bonds.
The ubiquitous calpains are inactive in the Ca 2ϩ -free state because the active site cleft between the two catalytic domains in the protease core is wedged open and restrained in this position by contact with neighboring domains (3, 4) . Realignment of the two catalytic domains upon calcium binding to two non-EF-hand sites in the core causes the zymogen to become active (31) . However, additional calcium regulatory mechanisms are built into the whole enzyme. These are thought to include release of the anchor peptide from the penta-EF-hand domain of the small subunit, dissociation of the small subunit from its penta-EF-hand domain partner in the large subunit, and calcium-induced changes in the C2-like domain adjacent to the protease core (43) . In at least the first of these steps, autolysis may play a role, whereby cleavage of the anchor peptide (originally speculated to be a classical propeptide) would break its contact with the small subunit and facilitate the structural changes required for activation of calpain.
Calpastatin, a specific calcium-dependent protein inhibitor of the ubiquitous calpains, adds another level of control to the already sophisticated regulation of calpain activation. It binds to the two penta-EF-hand domains, inhibiting calpain by a currently unknown mechanism, and so helps protect the cell from excessive calpain proteolysis. p94 is not inhibited by calpastatin (8) . Indeed, it lacks a small subunit and therefore lacks one of the calpastatin binding sites (20, 24) . It is possible that insertion of an autoinhibitory sequence such as IS1 in an otherwise conserved calpain scaffold provides another calciumdependent control mechanism that might compensate for the absence of small subunit-dependent regulatory mechanisms that are present in the ubiquitous calpains.
